No CrossRef data available.
Article contents
An RNA-seq transcriptome analysis for investigating the anti-lung cancer activity of medicinal Cuscuta chinensis Lam plant
Published online by Cambridge University Press: 05 December 2022
Abstract
Cuscuta chinensis Lam. is a traditional medicinal herb used to treat female sterility and male reproductive system disorders. However, the anti-lung cancer properties of Cuscuta chinensis Lam. and possible molecular mechanisms have yet to be explored. Thus, the study’s main purpose was to evaluate in vitro and in vivo anti-lung cancer properties of C. chinensis water extract (CLW) in human lung adenocarcinomas and the underlying molecular mechanism involved. Our results demonstrated that CLW caused a significant inhibition of cell viability and induced G1 cycle arrest in lung cancer cells. Furthermore, RNA-seq transcriptome analysis revealed 602 common genes with a significant expression in A549 and H1650 cells under CLW treatment. Functional enrichment analysis suggested that these common genes regulated by CLW mainly involve lung cancer cell proliferation, metastases and apoptosis processes. In addition, forty-six common genes (> 2-fold change) regulated by CLW in A549 and H1650 cells were selected for further validation. In vitro quantitative real-time PCR results confirmed that twelve genes were up-regulated, and four genes were down-regulated in A549 and H1650 cells. The in vivo experiment demonstrated CLW could significantly decrease tumour volume and tumour weight of mice compared with the control group. Moreover, in vivo quantitative real-time PCR results revealed that C11orf96, FGFBP1, FOSB and NPTX1 genes were up-regulated and EGR1, GBP4 and MAP2K6 genes were down-regulated in tumour tissues compared with the control group. These data strongly suggest that CLW could be developed as an efficacious drug for lung cancer treatment.
- Type
- Research Article
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press on behalf of The Nutrition Society
References
Bray, F, Ferlay, J, Soerjomataram, I, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68, 394–424.Google ScholarPubMed
Pourhanifeh, MH, Sharifi, M, Reiter, RJ, et al. (2019) Melatonin and non-small cell lung cancer: new insights into signaling pathways. Cancer Cell Int 19, 131.CrossRefGoogle ScholarPubMed
Hirsch, FR, Scagliotti, GV, Mulshine, JL, et al. (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389, 299–311.CrossRefGoogle ScholarPubMed
Liu, SH & Cheng, YC (2012) Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 140, 614–623.CrossRefGoogle ScholarPubMed
Zhai, B, Zhang, N, Han, X, et al. (2019) Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 114, 108812.CrossRefGoogle ScholarPubMed
Donnapee, S, Li, J, Yang, X, et al. (2014)
Cuscuta chinensis lam.: a systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine. J Ethnopharmacol 157, 292–308.CrossRefGoogle Scholar
Suresh, V, Sruthi, V, Padmaja, B, et al. (2011)
In vitro anti-inflammatory and anti-cancer activities of Cuscuta reflexa Roxb. J Ethnopharmacol 134, 872–877.CrossRefGoogle ScholarPubMed
Umehara, K, Nemoto, K, Ohkubo, T, et al. (2004) Isolation of a new 15-membered macrocyclic glycolipid lactone, Cuscutic Resinoside a from the seeds of Cuscuta chinensis: a stimulator of breast cancer cell proliferation. Planta Med 70, 299–304.Google ScholarPubMed
Jafarian, A, Ghannadi, A & Mohebi, B (2014) Cytotoxic effects of chloroform and hydroalcoholic extracts of aerial parts of Cuscuta chinensis and Cuscuta epithymum on Hela, HT29 and MDA-MB-468 tumor cells. Res Pharmaceut Sci 9, 115–122.Google ScholarPubMed
Nisa, M, Akbar, S, Tariq, M, et al. (1986) Effect of Cuscuta chinensis water extract on 7,12-dimethylbenz(a)anthracene-induced skin papillomas and carcinomas in mice. J Ethnopharmacol 18, 21–31.CrossRefGoogle Scholar
Maimaiti, A, Jing-Jing, L & Shi, L (2021) Investigating the acute and sub-acute toxicity of medicinal Cuscuta chinensis lam plant. J Ethnopharmacol 273, 114005.CrossRefGoogle ScholarPubMed
Maimaiti, A, Aili, A, Kuerban, H, et al. (2018) VDAC1 Mediated anticancer activity of gallic acid in human lung adenocarcinoma A549 cells. Anti-Cancer Agent Med Chem 18, 255–262.CrossRefGoogle ScholarPubMed
Maimaiti, A, Xingliang, L & Shi, L (2022) In vitro and in vivo anti-lung cancer activity of emodin: a RNA-seq transcriptome analysis. Curr Med Chem (Epublication ahead of print version 21 September 2022).CrossRefGoogle Scholar
Hrdlickova, R, Toloue, M & Tian, B (2017) RNA-Seq methods for transcriptome analysis. Wiley Interdiscip Rev: RNA 8, e1364.Google ScholarPubMed
Wang, J, Dean, DC, Hornicek, FJ, et al. (2019) RNA sequencing (RNA-Seq) and its application in ovarian cancer. Gynecol Oncol 152, 194–201.CrossRefGoogle ScholarPubMed
Maimaiti, A, Abudoukeremu, K, Tie, L, et al. (2015) MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. Gene 558, 271–277.CrossRefGoogle ScholarPubMed
Sun, Y, Liu, WZ, Liu, T, et al. (2015) Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35, 600–604.CrossRefGoogle ScholarPubMed
Li, G, Yang, J, Zhao, G, et al. (2021) Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area. J Cell Mol Med 25, 2872–2884.CrossRefGoogle ScholarPubMed
Huang, W, Chen, Z, Shang, X, et al. (2015) Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology 61, 1920–1933.CrossRefGoogle ScholarPubMed
Ray, R, Cabal-Manzano, R, Moser, AR, et al. (2003) Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res 63, 8085–8089.Google ScholarPubMed
Na, HH & Kim, KC (2018) SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells. Biochem Biophys Res Commun 495, 512–518.CrossRefGoogle ScholarPubMed
Ting, CH, Lee, KY, Wu, SM, et al. (2019) FOSB-PCDHB13 axis disrupts the microtubule network in non-small cell lung cancer. Cancers 11, 107.CrossRefGoogle ScholarPubMed
Peng, X, Pan, K, Zhao, W, et al. (2018) NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression. Cell Biol Int 42, 589–597.CrossRefGoogle ScholarPubMed
Zhou, C, Qin, Y, Xie, Z, et al. (2015) NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer. Biochem Biophys Res Commun 458, 381–386.CrossRefGoogle ScholarPubMed
Wang, Q, Wang, X, Liang, Q, et al. (2018) Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma. Oncol Lett 15, 7914–7922.Google ScholarPubMed
Li, Z, Fu, J, Li, N, et al. (2018) Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 505, 274–281.CrossRefGoogle ScholarPubMed
Li, L, Ameri, AH, Wang, S, et al. (2019) EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene 38, 6241–6255.CrossRefGoogle ScholarPubMed
Li, TT, Liu, MR & Pei, DS (2019) Friend or foe, the role of EGR-1 in cancer. Med Oncol 37, 7.CrossRefGoogle ScholarPubMed
Maimaiti et al. supplementary material
Tables S1-S7
File
14.8 MB
Maimaiti et al. supplementary material
Figure S1
Image
703.6 KB